Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ZNTL
#3078
Zentalis Pharmaceuticals, Inc. Common Stock
2.3
9
-0.42%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.42%
Aylık değişim
-18.98%
6 aylık değişim
+32.78%
Yıllık değişim
+17.73%
Önceki kapanış
2.4
0
Open
2.3
9
Bid
Ask
Low
2.3
9
High
2.3
9
Hacim
70
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ZNTL
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
41.04 M
45.56 M
59.42 M
70.96 M
71.81 M
—
Valuation ratios
Enterprise value
2.1 B
3.77 B
1.18 B
1.11 B
183.69 M
372.27 M
Price to earnings ratio
—
-22.6
-4.61
-3.58
-1.3
-3.04
Price to sales ratio
—
239.22 K
19.49 K
1 162.1
3.19
14.47
Price to cash flow ratio
—
-23.29
-6.67
-5.03
-1.26
-3.36
Price to book ratio
—
3.31
0.67
2.39
0.64
0.88
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.32
0.35
0.44
0.53
0.39
0.35
Return on equity %
0.35
0.44
0.55
0.67
0.49
0.45
Return on invested capital %
222.76
444.81
540.5
477.87
396.7
875.44
Gross margin %
—
100
100
100
100
—
Operating margin %
—
1.44 M
405.87 K
33.28 K
283.57
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
1.06 M
422.87 K
32.47 K
245.96
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
12.07
7.98
7.98
7.16
7.32
30
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0
0
0
0.14
0.06
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
3.61
3.1
3.18
2.4
1.87
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
5.49
6.11
2.16
6.05
16.53
Net current asset value per share
—
8.22
8.55
7.59
5.43
18.54
Tangible book value per share
—
25.29
30.75
6.63
4.74
16.18
Working capital per share
—
7.19
7.48
6.53
4.69
16.05
Book value per share
—
25.38
30.82
6.69
4.74
16.18
Haberler
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
Zentalis Pharmaceuticals PAO 7,8 bin dolarlık hisse satışı gerçekleştirdi
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Leerink Partners, Zentalis Pharmaceuticals için hisse fiyat hedefini 2 dolara düşürdü
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress